Pyridostigmine induced heart block requiring ICU admission

Pyridostigmine induced heart block requiring ICU admission

Myasthenia gravis is an autoimmune disorder that effects an estimated 20 people per 100,000 in the USA per year. Pyridostigmine is a common drug used in the symptomatic treatment of myasthenia gravis. While generally safe and effective, a rare set of patients treated with pyridostigmine encounter ca...

Full description

Bibliographic Details
Main Authors: Benjamin Chaucer, Dustin Whelan, Dronacharya Lamichhane
Format: Article
Language:English
Published: Greater Baltimore Medical Center 2018-09-01
Series:Journal of Community Hospital Internal Medicine Perspectives
Subjects:
Heart block
pyridostigmine
ICU
EKG
myasthenia gravis
Online Access:http://dx.doi.org/10.1080/20009666.2018.1527668

Internet

http://dx.doi.org/10.1080/20009666.2018.1527668

Similar Items